About CLINUVEL

Corporate Governance

The CLINUVEL Board is committed to good corporate governance. CLINUVEL's corporate governance policies are available for review and download via the links below.

 Date  Title Download
 February 2017  Corporate Governance Protocol Download
 February 2017  Board Charter Download
 August 2015  Remuneration Committee Charter Download
 June 2015  Audit & Risk Committee Charter Download
 July 2017  Diversity Policy Download
 February 2017  Nomination Committee Charter Download

2016 Corporate Governance Statement

CLINUVEL's 2016 Corporate Governance Statement can be downloaded here.

Latest Company Announcements

19 September 2017

CLINUVEL PROVIDES UPDATE ON SCENESSE® FDA FILING

CLINUVEL PHARMACEUTICALS LTD today announced an update on its submission of the New Drug Application (NDA) for CLINUVEL’s drug SCENESSE® (afamelanotide 16 mg) to the US Food and Drug Administration (FDA).

Read More
06 September 2017

Appendix 3B

Appendix 3B - New issue announcement

Read More
30 August 2017

Appendix 4E - Preliminary Final Report 2016/17

Appendix 4E - Preliminary Final Report 2016/17

Read More
08 August 2017

Form 604, 09 August 2017

Notice of change of interests of substantial holder

Read More
31 July 2017

Appendix 4C - Quarterly report

Appendix 4C

Read More
25 July 2017

CLINUVEL Newsletter - July 2017

For those who have followed the Company over the years, the journey of our teams has most often been counter-current to arrive at the present point.

Read More

Quick Links